JIUDIAN PHARMACEUTICAL has been approved to conduct clinical trials for two drugs

According to the Zhitong Finance APP, JIUDIAN PHARMACEUTICAL announced that the company recently received the "Drug Clinical Trial Approval Notice" issued by the National Medical Products Administration. After completing the relevant preparatory work, it will carry out clinical trial research. The approved clinical trials include: JIZM01 for clinical trials of closed soft tissue contusions and joint sprains, and JIZM02 for clinical trials of shoulder periarthritis

According to the Zhitong Finance APP, JIUDIAN PHARMACEUTICAL (300705.SZ) announced that the company recently received the "Drug Clinical Trial Approval Notification" issued by the National Medical Products Administration. After completing the relevant preparatory work, it will carry out clinical trial research. The approved clinical trials include: JIZM01 for clinical trials of closed soft tissue contusions and joint sprains, and JIZM02 for clinical trials of shoulder periarthritis